We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $398M
1-Year Est. Return 22.87%
This Fund
S&P 500
This Quarter Est. Return
+19.63%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$172M
AUM Growth
+$31.4M
Cap. Flow
+$6.81M
Cap. Flow %
3.95%
Top 10 Hldgs %
31.07%
Holding
144
New
12
Increased
10
Reduced
22
Closed
4

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.52M
2
NKE icon
Nike
NKE
+$1.55M
3
IRM icon
Iron Mountain
IRM
+$1.14M
4
AMZN icon
Amazon
AMZN
+$725K
5
ABBV icon
AbbVie
ABBV
+$337K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.61M
2
AGO icon
Assured Guaranty
AGO
+$1.43M
3
CLF icon
Cleveland-Cliffs
CLF
+$199K
4
AYTU icon
AYTU BioPharma
AYTU
+$199K
5
TBT icon
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
+$166K

Sector Composition

Rank Sector Weight
1 Healthcare 21.93%
2 Technology 18.94%
3 Industrials 10.96%
4 Financials 10.71%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YUMC icon
26
Yum China
YUMC
$15.1B
$2.13M 1.24%
44,400
– –
XIFR
27
XPLR Infrastructure LP
XIFR
$1.13B
$2.07M 1.2%
40,300
– –
PANW icon
28
Palo Alto Networks
PANW
$292B
$2.06M 1.19%
53,700
– –
QQQ icon
29
Invesco QQQ Trust
QQQ
$466B
$2.02M 1.17%
8,150
– –
NOC icon
30
Northrop Grumman
NOC
$74.1B
$1.96M 1.14%
6,388
– –
BA icon
31
Boeing
BA
$169B
$1.93M 1.12%
10,535
– –
AZN icon
32
AstraZeneca
AZN
$262B
$1.87M 1.09%
17,700
– –
MRK icon
33
Merck
MRK
$315B
$1.86M 1.08%
25,189
+262
+1% +$19.7K
DEO icon
34
Diageo
DEO
$46.7B
$1.83M 1.06%
13,616
– –
UPS icon
35
United Parcel Service
UPS
$100B
$1.78M 1.03%
16,050
+2,350
+17% +$235K
CVS icon
36
CVS Health
CVS
$137B
$1.75M 1.02%
26,980
– –
SWK icon
37
Stanley Black & Decker
SWK
$14B
$1.73M 1%
12,400
– –
NUE icon
38
Nucor
NUE
$53.9B
$1.72M 1%
41,617
– –
NKE icon
39
Nike
NKE
$64.9B
$1.65M 0.96%
+16,795
New +$1.55M
QCOM icon
40
Qualcomm
QCOM
$181B
$1.6M 0.93%
17,525
– –
AMZN icon
41
Amazon
AMZN
$2.66T
$1.57M 0.91%
11,360
+6,000
+112% +$725K
ABT icon
42
Abbott
ABT
$175B
$1.54M 0.89%
16,800
– –
DHR icon
43
Danaher
DHR
$144B
$1.47M 0.85%
9,347
– –
SPY icon
44
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$1.45M 0.84%
4,700
– –
HD icon
45
Home Depot
HD
$338B
$1.36M 0.79%
5,449
– –
HES
46
DELISTED
Hess
HES
$1.33M 0.77%
25,750
– –
IFF icon
47
International Flavors & Fragrances
IFF
$20B
$1.26M 0.73%
10,300
-158
-2% -$20K
CL icon
48
Colgate-Palmolive
CL
$74.4B
$1.25M 0.73%
17,120
– –
IRM icon
49
Iron Mountain
IRM
$36.8B
$1.25M 0.72%
+45,300
New +$1.14M
BRK.B icon
50
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.22M 0.71%
6,840
– –
1
2
3 4 5

Similar funds

CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
LSA
Lansing Street Advisors Ambler, Pennsylvania $397M AUM 18.7% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return

Searle & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Searle & Co held 144 positions worth $172M, up 22% from $141M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Searle & Co deployed $6.81M of net new capital in Q2 2020, opening 12 new positions and adding to 10 existing holdings. Its largest new stake was Nike: 16,795 shares worth $1.65M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AYTU BioPharma, an estimated $199K trimmed.

  • Searle & Co's largest Q2 2020 buy was Nike: 16,795 shares worth $1.65M.
  • Searle & Co added most to Apple in Q2 2020, an estimated $4.52M increase.
  • Searle & Co's biggest Q2 2020 reduction was AYTU BioPharma, cutting an estimated $199K.
  • Searle & Co fully exited Allergan plc in Q2 2020, selling an estimated $1.61M.
  • Searle & Co's ten largest holdings make up 31% of its $172M portfolio in Q2 2020.
  • Searle & Co opened 12 new positions and closed 4 in Q2 2020.
  • Searle & Co's portfolio value rose 22% quarter-over-quarter to $172M.

Based on Searle & Co's 13F filing for Q2 2020, filed 3 Aug 2020.